Always check for changes in color or cloudiness, which means the peptide may no longer be good to use
Shuwa HA, Shaw TN, Knight SB, Wemyss K, McClure FA, Pearmain L, et al
By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in a glucose-dependent manner, meaning insulin is released primarily when blood glucose levels are elevated
Metabolic parameters including glucose tolerance, insulin sensitivity, and IGF-1 levels were monitored throughout the treatment period, confirming that the favorable metabolic profile persisted with chronic use
Ultrasound Med Biol
SURMOUNT-5 trial: 8.3% mean weight loss Glapp users: 10.1% mean weight loss Relative improvement: +21.7% The Broader Scientific Conversation Our findings dont exist in isolation